Comorbidity in acute porphyria

It's a 2-for-1 podcast as Dr Mattias Lissing of the Karolinska Institute joins us to discuss two recent papers looking at cancer risk, comorbidity and mortality in the acute porphyrias. Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals Mattias Lissing, et al https://doi.org/10.1002/jimd.12583 Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case–control study of 188 patients Mattias Lissing, et al https://doi.org/10.1002/jimd.12676